The Association of Depressive Symptoms With Plasma C-Reactive Protein in Patients With Major Depressive Disorder Under Treatment

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 108

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IRJU-19-4_010

تاریخ نمایه سازی: 5 دی 1402

Abstract:

Objectives: This study evaluates the relationship between plasma high sensitive c-reactive protein (HSCRP) in patients with Major Depressive Disorder (MDD) under therapy. Methods: This cross-sectional study included ۹۰ patients with MDD that had been diagnosed previously to confirm their matching «DSM-۵ criteria for MDD version ۷.۰.۲,» employing the «mini-international neuropsychiatric interview.» Also, they were on antidepressants prescriptions for at least ۴ months. The criteria of MDD were based on the self-administered inquiry forms for evaluating depression severity, comprising the ۹-item Patient Health Questionnaire (PHQ-۹) depression module. A venous blood sample was collected from all participants for White Blood Cells (WBCs) counts and HSCRP assays. Besides their BMI calculations, SPSS v. ۲۳, was used for all statistical tests. Results: HSCRP mean serum levels were within normal ranges among MDD patients. The Mean±SD age of the MDD patients was ۳۹.۵±۰.۹ years, and most of them were obese; their Mean±SD BMI was ۳۲.۹±۱۵.۸ kg/m۲. The mean WBCs count of the participants was within the normal ranges. The ratio of male/female participants in this study was ۱.۶۴:۱. There was a non-significant difference between the sexes in all study parameters: no significant variations in the distribution of HSCRP levels according to the scores of depression severity. There was no significant variation in the distribution of WBCs counts according to the severity of depressive thoughts. A receiver operating characteristic curve (when tested for the diagnostic ability of HSCRP) revealed poor predictability to distinguish those with severe MDD from those with no or mild depressive thoughts: area under the curve=۰.۴۸۴, sensitivity=۰.۵۲, specificity=۰.۴۶, and P>۰.۰۵.  Discussion: The outcomes of our study highlighted the importance of low-grade inflammation as a risk factor of the onset or even worsening of depression in patients with MDD. This finding is reflected by a significant difference in the mean levels of serum HSCRP between those having mild and severe PHQ-۹ scores. However, the mean serum levels of HSCRP were not correlated with the severity of depressive symptoms.

Keywords:

Major Depressive Disorder (MDD) , The ۹-Item Patient Health Questionnaire (PHQ-۹) , C-Reactive Protein (CRP) , Depression , Low-grade inflammation

Authors

Azher Nema Mohammed Al-Agam

Department of Psychiatry, Merjan Teaching Hospital, Babil Health Directorate, Babylon, Iraq.

Ammar Waheeb Obeiad

Merjan Teaching Hospital, Babil Health Directorate, Babylon, Iraq.

Mahir Abdulkadhum Khudhair Alzughaibi

Department of Pharmacology and Toxicology, School of Pharmacy, University of Babylon, Hilla City, Babylon, Iraq.

Hayder Abdul-Amir M. Al-Hindy

Department of Pharmacology and Toxicology, School of Pharmacy, University of Babylon, Hilla City, Babylon, Iraq.

Amer Fadhil Alhaider

Department of Medicine, School of Medicine, Karbala University, Karbala, Iraq.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Moussavi S CS, Verdes E, Tandon A, Patel V, Ustun ...
  • Van der Kooy K, van Hout H, Marwijk H, Marten ...
  • Rosanski A BJ, Davidson KW, Saab PG, Kubzansky L. . ...
  • J. Sundquist XL, S. E. Johansson, and K. Sundquist Depression ...
  • W. V. R. Vieweg DAJ, A. Fernandez et al. Treatment ...
  • Lee C-H, Giuliani F. The Role of Inflammation in Depression ...
  • Ernst M, Brähler E, Otten D, Werner AM, Tibubos AN, ...
  • Hayder Abdul-Amir Makki Al-Hindy, Ali Jihad Hemid Al-Athari, Mazin J. ...
  • Qasim J. HS, Ghada H., Hayder AA. High-Sensitivity C-reactive protein ...
  • Raghdan Z. AKS, Dleikh F., Al-Hindy H. Is There any ...
  • Samer MM. AS, Hayder AA., Mazin JM. C-Reactive Protein is ...
  • Amir Al-Mumin HA-AMA-H, Mazin JM. Combined Assessments of Multi-panel Biomarkers ...
  • Asseel K. Shaker RA-S, Raad Jasim, Hayder Abdul-Amir Makki Al-Hindy. ...
  • Hajir Karim Abdul-Husseein FSD, Ameera Jasim Al-Aaraji, Hayder Abdul-Amir Makki ...
  • Hayder Abdul-Amir Maki Al-hindi MJM, Thekra Abid Jaber Al-kashwan, Ahmed ...
  • G. Fondab JAM-F, M. Faugereab, L. Boyerab, C. Faget-Agiusab, C. ...
  • Maria C. Pitharouli SPH, Kylie P. Glanville, Jonathan R.I. Coleman, ...
  • Ma Y, Chiriboga DE, Pagoto SL, Rosal MC, Li W, ...
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, ...
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-۹: validity of ...
  • "NIMH » Depression Basics". www.nimh.nih.gov. ۲۰۱۶. Retrieved ۲۲ October ۲۰۲۰ ...
  • Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. ...
  • Smith RS. The macrophage theory of depression. Medical hypotheses. ۱۹۹۱;۳۵(۴):۲۹۸-۳۰۶. ...
  • Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu ...
  • Blume J, Douglas SD, Evans DL. Immune suppression and immune ...
  • Grosse L, Hoogenboezem T, Ambrée O, Bellingrath S, Jörgens S, ...
  • Fried EI, von Stockert S, Haslbeck JMB, Lamers F, Schoevers ...
  • Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of ...
  • Mohamed AE, El-Latif RRA, Youssef AM, Ibrahim AS. C-reactive protein ...
  • Horn SR, Long MM, Nelson BW, Allen NB, Fisher PA, ...
  • Häfner S, Emeny RT, Lacruz ME, Baumert J, Herder C, ...
  • A. Nazmi IOOaCGV. Correlates of C-reactive protein levels in young ...
  • Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovascular drug reviews. ۲۰۰۶;۲۴(۱):۳۳-۵۰. ...
  • Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is ...
  • Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I. ...
  • Hollon SD, Thase ME, Markowitz JC. Treatment and Prevention of ...
  • O'Connor MF, Bower JE, Cho HJ, Creswell JD, Dimitrov S, ...
  • Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, ...
  • نمایش کامل مراجع